Filter By Category
Archives
Share on -
ASIMADOLINE
Generic Name: ASIMADOLINE
ABSTRACT -
Asimadoline is an investigational peripherally selective kappa-opioid receptor agonist studied for visceral pain, irritable bowel syndrome, and related gastrointestinal pain conditions. Its design aims to reduce central opioid effects while modulating peripheral sensory pathways. It is not a broadly approved routine analgesic.
DOSAGE -
No approved standard dosage is established. Oral dosing has been evaluated in clinical studies; regimen and eligibility depend on the protocol and target condition. It should not be used as an unsupervised opioid substitute.
SIDE EFFECTS–
- Possible or reported side effects may include:
- Nausea
- Constipation or diarrhea
- Abdominal discomfort
- Dizziness
- Headache
- Fatigue
- Dry mouth
- Somnolence at higher exposure
- Mood changes are possible with opioid-pathway agents
ALLERGIC REACTIONS -
Hypersensitivity symptoms include rash, hives, swelling, wheezing, or anaphylaxis.
DRUG INTERACTIONS-
Use caution with:
- Other opioid agonists or antagonists
- CNS depressants or alcohol
- Medicines affecting gastrointestinal motility
- CYP-metabolized medicines if protocol specifies
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTIONS–
Assess bowel pattern, abdominal pain diagnosis, hepatic/renal function, psychiatric history, pregnancy status, and opioid exposure.
Avoid use in obstructive bowel disease unless specifically evaluated.
WARNINGS –
- Not approved as a general pain medicine.
- Use only under specialist or clinical-trial supervision.
- Keep out of reach of children.
- In case of overdose, severe reaction, or clinical deterioration, seek immediate medical attention.
Share on -
. Developed by